Advertisement

Supportive Care in Cancer

, Volume 26, Issue 1, pp 61–79 | Cite as

The impact of specialized palliative care on cancer patients’ health-related quality of life: a systematic review and meta-analysis

  • Angelos P. KassianosEmail author
  • Myria Ioannou
  • Marianna Koutsantoni
  • Haris Charalambous
Review Article

Abstract

Purpose

Specialized palliative care (SPC) is currently underutilized or provided late in cancer care. The aim of this systematic review and meta-analysis is to critically evaluate the impact of SPC on patients’ health-related quality of life (HRQoL).

Methods

Five databases were searched through June 2016. Randomized controlled trials (RCTs) and prospective studies using a pre- and post- assessment of HRQoL were included. The PRISMA reporting statement was followed. Criteria from available checklists were used to evaluate the studies’ quality. A meta-analysis followed using random-effect models separately for RCTs and non-RCTs.

Results

Eleven studies including five RCTs and 2939 cancer patients published between 2001 and 2014 were identified. There was improved HRQoL in patients with cancer following SPC especially in symptoms like pain, nausea, and fatigue as well as improvement of physical and psychological functioning. Less or no improvements were observed in social and spiritual domains. In general, studies of inpatients showed a larger benefit from SPC than studies of outpatients whereas patients’ age and treatment duration did not moderate the impact of SPC. Methodological shortcomings of included studies include high attrition rates, low precision, and power and poor reporting of control procedures.

Conclusions

The methodological problems and publication bias call for higher-quality studies to be designed, funded, and published. However, there is a clear message that SPC is multi-disciplinary and aims at palliation of symptoms and burden in line with current recommendations.

Keywords

Palliative care Specialized palliative care Cancer Quality of life Meta-analysis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

520_2017_3895_MOESM1_ESM.docx (29 kb)
ESM 1 (DOCX 28 kb).

References

  1. 1.
    Stewart BWKP, & Wild CP (2014) World cancer report 2014. 2014. Lyon CEDEX, FranceGoogle Scholar
  2. 2.
    Peppercorn JM, Smith TJ, Helft PR et al (2011) American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 29:755–760.  https://doi.org/10.1200/JCO.2010.33.1744 CrossRefPubMedGoogle Scholar
  3. 3.
    Care P (1999) Discussing palliative care with patients. Ann Intern Med 130:744–749CrossRefGoogle Scholar
  4. 4.
    Saito AM, Landrum MB, Neville BA et al (2011) The effect on survival of continuing chemotherapy to near death. BMC Palliat Care 10:14CrossRefGoogle Scholar
  5. 5.
    Von Gruenigen V, Daly B, Gibbons H et al (2008) Indicators of survival duration in ovarian cancer and implications for aggressiveness of care. Cancer 112:2221–2227CrossRefGoogle Scholar
  6. 6.
    Kao S, Shafiq J, Vardy J, Adams D (2009) Use of chemotherapy at end of life in oncology patients. Ann Oncol 20:1555–1559CrossRefGoogle Scholar
  7. 7.
    Rose JH, O’Toole EE, Dawson NV et al (2004) Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 22:4907–4917CrossRefGoogle Scholar
  8. 8.
    Charalambous H, Silbermann M (2012) Clinically based palliative care training is needed urgently for all oncologists. J Clin Oncol 30:4042–4043CrossRefGoogle Scholar
  9. 9.
    Wright AA, Zhang B, Ray A et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665–1673CrossRefGoogle Scholar
  10. 10.
    World Health Organisation (2003) Palliative care: what is it http://www.who.int/cancer/palliative/definition/en/. Accessed 01 June 2016
  11. 11.
    Echteld MA, van Zuylen L, Bannink M et al (2007) Changes in and correlates of individual quality of life in advanced cancer patients admitted to an academic unit for palliative care. Palliat Med 21:199–205CrossRefGoogle Scholar
  12. 12.
    Higginson IJ, Finlay IG, Goodwin DM et al (2003) Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manag 25:150–168CrossRefGoogle Scholar
  13. 13.
    Levy MH, Back A, Benedetti C et al (2009) Palliative Care. J Natl Compr Cancer Netw 7:436–473CrossRefGoogle Scholar
  14. 14.
    Ferris FD, Bruera E, Cherny N et al (2009) Palliative cancer care a decade later: accomplishments, the need, next steps—from the American Society of Clinical Oncology. J Clin Oncol 27:3052–3058CrossRefGoogle Scholar
  15. 15.
    Quill TE, Abernethy AP (2013) Generalist plus specialist palliative care—creating a more sustainable model. N Engl J Med 368:1173–1175CrossRefGoogle Scholar
  16. 16.
    Strand JJ, Mansel JK, Swetz KM, others (2014) The growth of palliative care. Minn Med 97:39–43Google Scholar
  17. 17.
    Kavalieratos D, Corbelli J, Zhang D et al (2016) Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 316:2104–2114CrossRefGoogle Scholar
  18. 18.
    Zimmermann C, Riechelmann R, Krzyzanowska M et al (2008) Effectiveness of specialized palliative care: a systematic review. JAMA 299:1698–1709CrossRefGoogle Scholar
  19. 19.
    Davis MP, Temel JS, Balboni T, Glare P (2015) A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med 4:99–121PubMedGoogle Scholar
  20. 20.
    Jenicek M (1989) Meta-analysis in medicine where we are and where we want to go. J Clin Epidemiol 42:35–44CrossRefGoogle Scholar
  21. 21.
    Byock I, Twohig JS, Merriman M, Collins K (2006) Promoting excellence in end-of-life care: a report on innovative models of palliative care. J Palliat Med 9:137–151CrossRefGoogle Scholar
  22. 22.
    Morrison RS, Meier DE (2004) Palliative Care. N Engl J Med 350:2582–2590.  https://doi.org/10.1056/NEJMcp035232 CrossRefPubMedGoogle Scholar
  23. 23.
    Field MJ, Cassel CK, others (1997) Approaching death: improving care at the end of life. National Academies Press, Washington DCGoogle Scholar
  24. 24.
    Foley K, & Gelband H (2001) Improving Palliative Care for Cancer, National Cancer Policy Board, National Research Council. National Academy of Sciences, 10Google Scholar
  25. 25.
    Smith TJ, Temin S, Alesi ER et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887CrossRefGoogle Scholar
  26. 26.
    Ferrell BR, Temel JS, Temin S et al (2016) Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:96–112.  https://doi.org/10.1200/JCO.2016.70.1474 CrossRefPubMedGoogle Scholar
  27. 27.
    Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269CrossRefGoogle Scholar
  28. 28.
    World Health Organization (2017) WHO definition of palliative care http://www.who.int/cancer/palliative/definition/en/ Accessed 24 Jul 2017
  29. 29.
    McGowan J, Sampson M, Lefebvre C (2010) An evidence based checklist for the Peer Review of Electronic Search Strategies (PRESS EBC). Evid Based Libr Inf Pract 5:149–154CrossRefGoogle Scholar
  30. 30.
    Slim K, Nini E, Forestier D et al (2003) Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg 73:712–716CrossRefGoogle Scholar
  31. 31.
    Chalmers TC, Smith H, Blackburn B et al (1981) A method for assessing the quality of a randomized control trial. Control Clin Trials 2:31–49CrossRefGoogle Scholar
  32. 32.
    Von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med 45:247–251CrossRefGoogle Scholar
  33. 33.
    Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRefGoogle Scholar
  34. 34.
    Mowatt G, Grimshaw JM, Davis DA, Mazmanian PE (2001) Getting evidence into practice: the work of the cochrane Effective Practice and Organization of Care Group (EPOC). J Contin Educ Heal Prof 21:55–60.  https://doi.org/10.1002/chp.1340210109 CrossRefGoogle Scholar
  35. 35.
    Des Jarlais DC, Lyles C, Crepaz N (2004) Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 94:361–366CrossRefGoogle Scholar
  36. 36.
    Shea BJ, Grimshaw JM, Wells GA et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:1CrossRefGoogle Scholar
  37. 37.
    Campbell MK, Piaggio G, Elbourne DR, & Altman DG (2012) Consort 2010 statement: extension to cluster randomised trials. BMJ 345:e5661Google Scholar
  38. 38.
    Ozcelik H, Fadiloglu C, Karabulut B, Uyar M (2014) Examining the effect of the case management model on patient results in the palliative care of patients with cancer. Am J Hosp Palliat Med 31:655–664CrossRefGoogle Scholar
  39. 39.
    Bischoff K, Weinberg V, Rabow MW (2013) Palliative and oncologic co-management: symptom management for outpatients with cancer. Support Care Cancer 21:3031–3037CrossRefGoogle Scholar
  40. 40.
    Strömgren AS, Sjogren P, Goldschmidt D et al (2005) A longitudinal study of palliative care. Cancer 103:1747–1755CrossRefGoogle Scholar
  41. 41.
    Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non–small-cell lung cancer. N Engl J Med 363:733–742CrossRefGoogle Scholar
  42. 42.
    Melin-Johansson C, Axelsson B, Gaston-Johansson F, Danielson E (2010) Significant improvement in quality of life of patients with incurable cancer after designation to a palliative homecare team. Eur J Cancer Care (Engl) 19:243–250CrossRefGoogle Scholar
  43. 43.
    Yamagishi A, Sato K, Miyashita M et al (2014) Changes in quality of care and quality of life of outpatients with advanced cancer after a regional palliative care intervention program. J Pain Symptom Manag 48:602–610CrossRefGoogle Scholar
  44. 44.
    Zimmermann C, Swami N, Krzyzanowska M et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383:1721–1730CrossRefGoogle Scholar
  45. 45.
    Jordhøy MS, Fayers P, Loge JH avard, et al (2001) Quality of life in palliative cancer care: results from a cluster randomized trial. J Clin Oncol 19:3884–3894CrossRefGoogle Scholar
  46. 46.
    Bakitas M, Lyons KD, Hegel MT et al (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA 302:741–749CrossRefGoogle Scholar
  47. 47.
    Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefGoogle Scholar
  48. 48.
    Cella D, Nowinski CJ (2002) Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 83:S10–S17CrossRefGoogle Scholar
  49. 49.
    Webster K, Cella D, Yost K (2003) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 1:79CrossRefGoogle Scholar
  50. 50.
    Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579CrossRefGoogle Scholar
  51. 51.
    Lyons KD, Bakitas M, Hegel MT et al (2009) Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative Care (FACIT-Pal) scale. J Pain Symptom Manag 37:23–32.  https://doi.org/10.1016/j.jpainsymman.2007.12.015 CrossRefGoogle Scholar
  52. 52.
    Cella DF, Bonomi AE, Lloyd SR et al (1995) Reliability and validity of the Functional Assessment of Cancer Therapy—Lung (FACT-L) quality of life instrument. Lung Cancer 12:199–220.  https://doi.org/10.1016/0169-5002(95)00450-F CrossRefPubMedGoogle Scholar
  53. 53.
    Peterman AH, Fitchett G, Brady MJ et al (2002) Measuring spiritual well-being in people with cancer: the Functional Assessment of Chronic Illness Therapy—Spiritual Well-Being Scale (FACIT-Sp). Ann Behav Med 24:49–58.  https://doi.org/10.1207/S15324796ABM2401_06 CrossRefPubMedGoogle Scholar
  54. 54.
    Steinhauser KE, Clipp EC, Bosworth HB et al (2004) Measuring quality of life at the end of life: validation of the QUAL-E. Palliat Support Care 2:3–14.  https://doi.org/10.1017/S1478951504040027 CrossRefPubMedGoogle Scholar
  55. 55.
    Cohen SR, Mount BM, Strobel MG, Bui F (1995) The McGill quality of life questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability. Palliat Med 9:207–219CrossRefGoogle Scholar
  56. 56.
    Browne JP, O’boyle CA, McGee HM et al (1997) Development of a direct weighting procedure for quality of life domains. Qual Life Res 6:301–309CrossRefGoogle Scholar
  57. 57.
    Bertil Axelsson P-OS (1999) Assessment of quality of life in palliative care: psychometric properties of a short questionnaire. Acta Oncol 38:229–237.  https://doi.org/10.1080/028418699431663 CrossRefGoogle Scholar
  58. 58.
    Cohen SR, Boston P, Mount BM, Porterfield P (2001) Changes in quality of life following admission to palliative care units. Palliat Med 15:363–371CrossRefGoogle Scholar
  59. 59.
    Morita T, Miyashita M, Yamagishi A et al (2013) Effects of a programme of interventions on regional comprehensive palliative care for patients with cancer: a mixed-methods study. Lancet Oncol 14:638–646CrossRefGoogle Scholar
  60. 60.
    Gaertner J, Siemens W, Daveson BA et al (2016) Of apples and oranges: lessons learned from the preparation of research protocols for systematic reviews exploring the effectiveness of specialist palliative care. BMC Palliat Care 15:43.  https://doi.org/10.1186/s12904-016-0110-y CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Song F, Hooper L, Loke Y (2013) Publication bias: what is it? How do we measure it? How do we avoid it? Open Access J Clin Trials 2013:71–81CrossRefGoogle Scholar
  62. 62.
    Nipp RD, Currow DC, Cherny NI et al (2015) Best supportive care in clinical trials: review of the inconsistency in control arm design. Br J Cancer 113:6–11CrossRefGoogle Scholar
  63. 63.
    Siouta N, Van Beek K, Van der Eerden ME et al (2016) Integrated palliative care in Europe: a qualitative systematic literature review of empirically-tested models in cancer and chronic disease. BMC Palliat Care 15:56CrossRefGoogle Scholar
  64. 64.
    American Board of Internal Medicine (2008) Hospice & Palliative Medicine Certification Policies http://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/hospice-palliative-medicine.aspx. Accessed 1 Mar 2017
  65. 65.
    Breuer B, Fleishman SB, Cruciani RA, Portenoy RK (2011) Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol 29:4769–4775CrossRefGoogle Scholar
  66. 66.
    Weinstein MC, Skinner JA (2010) Comparative effectiveness and health care spending—implications for reform. N Engl J Med 362:460–465CrossRefGoogle Scholar
  67. 67.
    Burke LA, Ryan AM (2014) The complex relationship between cost and quality in US health care. Virtual Mentor VM 16:124–130CrossRefGoogle Scholar
  68. 68.
    World Health Organization (2002) National cancer control programmes: policies and managerial guidelines. World Health OrganizationGoogle Scholar
  69. 69.
    Hui D, Elsayem A, De La Cruz M et al (2010) Availability and integration of palliative care at US cancer centers. JAMA 303:1054–1061CrossRefGoogle Scholar
  70. 70.
    Wentlandt K, Krzyzanowska MK, Swami N et al (2012) Referral practices of oncologists to specialized palliative care. J Clin Oncol 30:4380–4386CrossRefGoogle Scholar
  71. 71.
    Lynch T, Connor S, Clark D (2013) Mapping levels of palliative care development: a global update. J Pain Symptom Manag 45:1094–1106CrossRefGoogle Scholar
  72. 72.
    Meier DE, Beresford L (2008) Outpatient clinics are a new frontier for palliative care. J Palliat Med 11:823–828CrossRefGoogle Scholar
  73. 73.
    Levit L, Balogh E, Nass S et al (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. Inst. Med. Wash, DCCrossRefGoogle Scholar
  74. 74.
    Lamas D, Rosenbaum L (2012) Painful inequities—palliative care in developing countries. N Engl J Med 366:199–201.  https://doi.org/10.1056/NEJMp1113622 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Angelos P. Kassianos
    • 1
    Email author
  • Myria Ioannou
    • 2
  • Marianna Koutsantoni
    • 2
  • Haris Charalambous
    • 3
  1. 1.Department of Applied Health ResearchUniversity College LondonLondonUK
  2. 2.Department of PsychologyUniversity of CyprusNicosiaCyprus
  3. 3.Bank of Cyprus Oncology CentreNicosiaCyprus

Personalised recommendations